About SilverArc Capital
SilverArc Capital is a private equity firm focused on healthcare and biotech opportunities.
The firm is based in Boston, Massachusetts, with Andrew Timpson serving as the President and Chief Operating Officer.
SilverArc's notable investments include COXREL Pharmaceuticals (series D), Manifold (series B), Madulight Bio (seed), Congruence Therapeutics (venture round), Aardvark Therapeutics (series C), Unicycle Therapeutics (post-IPO), and Gossamer Bio (post-IPO).
People
- Andrew Timpson, President & COO
You last contacted this investor on .